Table 2.
Parameter (pg/mL) | LS | HS |
---|---|---|
N (F/M) | 30 (15/15) | |
Pro-inflammatory cytokines | ||
IFNγ | 1.26 [0.76–1.58] | 1.80 [1.31–4.85] * |
TNF-α | 7.55 ± 12.27 | 14.49 ± 16.23 * |
IL-6 | 2.24 [1.35–3.18] | 2.82 [1.93–3.53] |
IL-9 | 0.09 [0.05–0.23] | 0.19 [0.11–3.49] * |
IL-17A | 1.52 [0.89–4.67] | 2.02 [1.56–12.2] * |
IL-23 | 0.05 ± 0.02 | 0.05 ± 0.02 |
Anti-inflammatory (immunomodulatory) cytokines | ||
IL-10 | 0.44 [0.27–0.66] | 0.68 [0.44–3.60] * |
IL-21 | 168.2 ± 210.5 | 281.6 ± 296.8 |
IL-22 | 1.39 [1.10–2.18] | 1.88 [1.29–3.21] |
TGF-β1 | 36.6 ± 33.0 | 49.7 ± 31.6 * |
C3a Complement Component | 202.3 ± 159.4 | 204.5 ± 178.0 |
Soluble Cell Adhesion Molecules | ||
sICAM-1 | 1108 [444–1623] | 968 [537–1558] |
sVCAM-1 | 3342 [2195–4808] | 3230 [2524–4024] |
E-selectin (CD-62E) | 132.4 ± 47.5 | 130.5 ± 39.3 |
Endoglin | 1753 [1118–2679] | 1709 [1337–2599] |
Data are presented as the mean ± standard deviation (SD) (normally distributed data) or median and interquartile range (non-normally distributed data). LS—low salt; HS—high-salt; N—number of subjects; F—female; M—male; IFNγ—interferon gamma; TNF-α—tumor necrosis factor alpha; IL-6—interleukin 6; IL-9—interleukin 9; IL-17A—interleukin 17A; IL-23—interleukin 23; IL-10—interleukin 10; IL-21; interleukin 21; IL-22—interleukin 22; TGF-β1—transforming growth factor beta; cICAM-1—soluble intercellular adhesion molecule 1; sVCAM-1—soluble vascular cell adhesion molecule 1. * p < 0.05 LS vs. HS (Paired t-test or Wilcoxon signed-rank test).